The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $1,472.66 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4565470089 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of medical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $1,272.27 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The order is for delivery by May 15, 2024 and has a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract with DLA Troop Support Medical, valued up...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,252.44 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide...
The U.S. Defense Logistics Agency (DLA) awarded a $4,722.96 Firm Fixed Price delivery order contract (SPE2DB22D2108|SPE2DB24FU4GD) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the medication XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a $1,565.06 delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $5,575.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, to be delivered by January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and medical supplies to DLA Troop Support Medical facilities. This order does not have a...
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $1,312.65 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00...
The U.S. Department of Defense (DoD) Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,575.18 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,440.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a completion date of April 11, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The firm-fixed-price contract, valued at $1,990.45, has an ultimate completion date of August 29, 2024. AmerisourceBergen, through its Corporate Office Division, has been awarded multiple federal contracts and indefinite delivery contracts to provide a wide range of pharmaceutical products and...